NFKB1 and cancer: Further mechanistic study showed that ropivacaine significantly suppressed the expression of several key components of NF-κB pathway, including the phosphorylation of p65, IκBα and IKKα/β, indicating that ropivacaine decreased the adhesion of cancer cells via modulating CD62E expression by inhibiting the NF-κB pathway (107).